Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
Active, not recruiting · NCT04717700 · Registry updated 2025-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-03-18 | NCT04717700 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ida Bruun Kristensen | 1 |
| Karyopharm Therapeutics Inc | 25 |
| Odense Patient Data Explorative Network | 16 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | 32 |
| Førde Central Hospital | Førde | Norway | 2 |
| Haukeland University Hospital | Bergen | Norway | 52 |
| Kristiansund Hospital | Kristiansund | Norway | 1 |
| North Estonia Medical Centre Foundation | Tallinn | Estonia | 11 |
| Odense University Hospital | Odense | Denmark | 57 |
| Oslo Universitets Hospital | Oslo | Norway | 1 |
| Regionshospitalet Gødstrup | Gødstrup | Denmark | 3 |
| St. Olavs University Hospital | Trondheim | Norway | 25 |
| Stavanger University Hospital | Stavanger | Norway | 36 |
| Sydvestjysk Sygehus Esbjerg | Esbjerg | Denmark | 1 |